Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Category: Drugs
Remove filter for
Last updated: 2020
Remove filter for
Type: Public advisory
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 1 - 10 of 10 items.
Unauthorized nicotine buccal pouches may pose serious health risks
AlertPublic advisory | 2020-11-02
Updates to safety labelling for benzodiazepines and benzodiazepine-like drugs
AlertPublic advisory | 2020-10-30
Recalls of Regener-Eyes Ophthalmic Solution and Regener-Eyes Ophthalmic Solution Lite
AlertPublic advisory | 2020-10-30
An unauthorized biologic eye drop, Regener-Eyes Ophthalmic Solution, recalled after Edmonton clinic found to be importing and selling it
AlertPublic advisory | 2020-10-04
Allergan Inc. voluntarily withdraws its drug Fibristal, used to treat uterine fibroids, from the Canadian market
AlertPublic advisory | 2020-09-30
All strengths of MAR-Diltiazem CD, a drug used to treat angina and hypertension, have been recalled because of dosing concerns
AlertPublic advisory | 2020-09-24
Non-prescription pain relief products containing codeine are not recommended for use in people under 18 years of age
AlertPublic advisory | 2020-07-31
Remdesivir authorized with conditions for the treatment of patients in Canada with severe COVID-19 symptoms
AlertPublic advisory | 2020-07-28